Related Experiment Video
Updated: Jun 22, 2026
08:33
A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers
Published on: January 5, 2024
[Fibromyalgia prevalence in Tunisia]
Mohamed Guermazi1, S Ghroubi, Mona Sellami
1Service de médecine physique et de réadaptation fonctionnelle CHU Habib Bourguiba, 3029 Sfax Tunisie.
La Tunisie Medicale
|May 29, 2009
Summary
Fibromyalgia (FM) prevalence in Tunisia was estimated using the LFES-SQ questionnaire and ACR criteria. The study found FM prevalence to be at least 8.27% in the Tunisian population.
Area of Science:
- Rheumatology
- Epidemiology
- Public Health
Context:
- Fibromyalgia (FM) is a chronic condition characterized by widespread pain.
- Estimating the prevalence of FM is crucial for public health resource allocation and patient care.
- Tunisia lacks comprehensive epidemiological data on FM.
Purpose:
- To estimate the prevalence of fibromyalgia (FM) in Tunisia.
- To evaluate the diagnostic accuracy of the London Fibromyalgia Epidemiology Study Screening Questionnaire (LFES-SQ).
Summary:
- A cross-sectional study surveyed 1000 individuals in Sfax, Tunisia, using the LFES-SQ. Positive cases were confirmed via 1999 ACR criteria.
- The LFES-SQ demonstrated 90.8% specificity and 79.4% sensitivity.
- Fibromyalgia prevalence in Tunisia was calculated using Bayes theorem, ranging from 8.27% to 12.3%.
Impact:
- This study provides the first epidemiological data on FM prevalence in Tunisia.
- Findings highlight the need for increased awareness and management strategies for FM in the region.
- The validated screening questionnaire can aid future epidemiological research in similar populations.
